G581-0301 Screening compound: 4-(4-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-5-one

G581-0301 Screening compound: 4-(4-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-5-one
G581-0301 Screening compound: 4-(4-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G581-0301
4-(4-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G581-0301

Molecular Formula

C26H31N5O4 (C26 H31 N5 O4)

Compound Name

4-(4-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-5-one

IUPAC name

4-(4-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-4-oxobutyl)-2-(1-methyl-1H-indol-3-yl)-4H5H6H7H-pyrazolo[15-a]pyrimidin-5-one

SMILES

Cn1c(cccc2)c2c(-c2nn(CCC(N3CCCC(N(CC4)CCC44OCCO4)=O)=O)c3c2)c1

InChI

InChI=1S/C26H31N5O4/c1-28-18-20(19-5-2-3-6-22(19)28)21-17-23-30(25(33)8-12-31(23)27-21)11-4-7-24(32)29-13-9-26(10-14-29)34-15-16-35-26/h2-3,5-6,17-18H,4,7-16H2,1H3

InChI Key

OSVCENIUDLCMET-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15020597

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.550

Distribution Coefficient, logD

1.550

Water Solubility, LogSw

-2.15

Polar Surface Area

61.388

Acid Dissociation Constant (pKa)

22.67

Base Dissociation Constant (pKb)

2.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

G581-0301 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G581-0301 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G581-0301?
Check Price and Availability of G581-0301, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G581-0301 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G581-0301
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G581-0301
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G581-0301 available by request